Sökning: onr:"swepub:oai:lup.lub.lu.se:0437140a-1589-498b-ac0f-9e4fd7e569e6" >
Gain of 1q as a pro...
Gain of 1q as a prognostic biomarker in Wilms Tumors (WTs) treated with preoperative chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 trial : A SIOP renal tumours biology consortium study
-
- Chagtai, Tasnim (författare)
- University College London
-
- Zill, Christina (författare)
- Julius Maximilian University of Würzburg
-
- Dainese, Linda (författare)
- Hôpital Armand Trousseau,Paris-Sorbonne University
-
visa fler...
-
- Wegert, Jenny (författare)
- Julius Maximilian University of Würzburg
-
- Savola, Suvi (författare)
- MRC-Holland
-
- Popov, Sergey (författare)
- University Hospital of Wales
-
- Mifsud, William (författare)
- University College London
-
- Vujanić, Gordan (författare)
- Cardiff University
-
- Sebire, Neil (författare)
- University College London
-
- Le Bouc, Yves (författare)
- Hôpital Armand Trousseau,Paris-Sorbonne University
-
- Ambros, Peter F. (författare)
- St. Anna Children's Hospital
-
- Kager, Leo (författare)
- St. Anna Children's Hospital
-
- O'Sullivan, Maureen J. (författare)
- Our Lady's Hospital for Sick Children
-
- Blaise, Annick (författare)
- Paris-Sorbonne University
-
- Bergeron, Christophe (författare)
- Centre Léon Bérard
-
- Mengelbier, Linda Holmquist (författare)
- Lund University,Lunds universitet,Avdelningen för klinisk genetik,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Genetics,Department of Laboratory Medicine,Faculty of Medicine
-
- Gisselsson, David (författare)
- Lund University,Lunds universitet,Avdelningen för klinisk genetik,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Clinical Genetics,Department of Laboratory Medicine,Faculty of Medicine
-
- Kool, Marcel (författare)
- German Cancer Research Centre
-
- Tytgat, Godelieve A M (författare)
- Princess Maxima Center for Pediatric Oncology/Hematology
-
- Van Den Heuvel-Eibrink, Marry M. (författare)
- Princess Maxima Center for Pediatric Oncology/Hematology
-
- Graf, Norbert (författare)
- Saarland University
-
- Van Tinteren, Harm (författare)
- Netherlands Cancer Institute
-
- Coulomb, Aurore (författare)
- Hôpital Armand Trousseau,Paris-Sorbonne University
-
- Gessler, Manfred (författare)
- Julius Maximilian University of Würzburg
-
- Williams, Richard Dafydd (författare)
- University College London
-
- Pritchard-Jones, Kathy (författare)
- University College London
-
visa färre...
-
(creator_code:org_t)
- 2016
- 2016
- Engelska 9 s.
-
Ingår i: Journal of Clinical Oncology. - 0732-183X. ; 34:26, s. 3195-3203
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Purpose: Wilms tumor (WT) is the most common pediatric renal tumor. Treatment planning under International Society of Paediatric Oncology (SIOP) protocols is based on staging and histologic assessment of response to preoperative chemotherapy. Despite high overall survival (OS), many relapses occur in patients without specific risk factors, and many successfully treated patients are exposed to treatments with significant risks of late effects. To investigate whether molecular biomarkers could improve risk stratification, we assessed 1q status and other potential copy number biomarkers in a large WT series. Materials and Methods: WT nephrectomy samples from 586 SIOP WT 2001 patients were analyzed using a multiplex ligation-dependent probe amplification (MLPA) assay that measured the copy number of 1q and other regions of interest. Results: One hundred sixty-seven (28%) of 586 WTs had 1q gain. Five-year event-free survival (EFS) was 75.0% in patients with 1q gain (95% CI, 68.5% to 82.0%) and 88.2% in patients without gain (95% CI, 85.0% to 91.4%). OS was 88.4% with gain (95% CI, 83.5% to 93.6%) and 94.4% without gain (95% CI, 92.1% to 96.7%). In univariable analysis, 1q gain was associated with poorer EFS (P < .001; hazard ratio, 2.33) and OS (P = .01; hazard ratio, 2.16). The association of 1q gain with poorer EFS retained significance in multivariable analysis adjusted for 1p and 16q loss, sex, stage, age, and histologic risk group. Gain of 1q remained associated with poorer EFS in tumor subsets limited to either intermediate-risk localized disease or nonanaplastic localized disease. Other notable aberrations associated with poorer EFS included MYCN gain and TP53 loss. Conclusion: Gain of 1q is a potentially valuable prognostic biomarker in WT, in addition to histologic response to preoperative chemotherapy and tumor stage.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Pediatrik (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Pediatrics (hsv//eng)
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Chagtai, Tasnim
-
Zill, Christina
-
Dainese, Linda
-
Wegert, Jenny
-
Savola, Suvi
-
Popov, Sergey
-
visa fler...
-
Mifsud, William
-
Vujanić, Gordan
-
Sebire, Neil
-
Le Bouc, Yves
-
Ambros, Peter F.
-
Kager, Leo
-
O'Sullivan, Maur ...
-
Blaise, Annick
-
Bergeron, Christ ...
-
Mengelbier, Lind ...
-
Gisselsson, Davi ...
-
Kool, Marcel
-
Tytgat, Godeliev ...
-
Van Den Heuvel-E ...
-
Graf, Norbert
-
Van Tinteren, Ha ...
-
Coulomb, Aurore
-
Gessler, Manfred
-
Williams, Richar ...
-
Pritchard-Jones, ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Pediatrik
- Artiklar i publikationen
-
Journal of Clini ...
- Av lärosätet
-
Lunds universitet